Skip to main content

Day: December 19, 2022

Webcomics Market to Hit USD 11.12 Billion by 2028 | Industry to Generate 6.1% CAGR during (2021-2028)

Written by Customer Service on . Posted in Mergers And Acquisitions.

Companies covered in Webcomics Market are Homestuck (United States), Penny Arcade Inc. (Redmond, WA, United States), The Oatmeal (Seattle, Washington, United States), Cucumber Quest (California, USA), Girl Genius (Seattle, WA, USA), Gunnerkrigg Court (Birmingham, United Kingdom), Stand Still, Stay Silent (Sweden), Brawl in the Family (United States), XKCD (United States), Lackadaisy (United States), Sandra and Woo (Germany), Scandinavia and the World (Denmark), and more players profiled. Pune, India, Dec. 19, 2022 (GLOBE NEWSWIRE) — According to Fortune Business Insights, the global webcomics market size is expected to gain momentum by reaching USD 11.12 billion by 2028 while exhibiting a CAGR of 6.1% between 2021 to 2028. In its report titled “Webcomics Market, 2021-2028,” Fortune Business Insights mentions that the...

Continue reading

Bionomics Reports Topline Results in PREVAIL Phase 2 Study of BNC210 in Social Anxiety Disorder

Written by Customer Service on . Posted in Public Companies.

BNC210 for Treatment of Social Anxiety Disorder (SAD) Did Not Meet Primary Endpoint Subjects with Confirmed SAD who Received BNC210 Exhibited Trends Toward Improvements Across Endpoints Compared to Placebo BNC210 Demonstrated Favourable Safety and Tolerability Profile Consistent with Prior Experience Company is Continuing Analysis of the Data and Evaluating Next Steps with Cash Runway into mid-2024ADELAIDE, Australia, Dec. 18, 2022 (GLOBE NEWSWIRE) — Bionomics Limited (Nasdaq: BNOX | ASX: BNO) (Bionomics or Company), a clinical-stage biopharmaceutical company developing novel, allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system (CNS) disorders with high unmet medical need, today announced results from its Phase 2 randomised, double-blind, placebo-controlled,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.